Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment.

Lymph node regression could be used as a predictor for pathological response. We developed a scoring system to predict the treatment response of patients with gastric cancer receiving neoadjuvant chemotherapy. The scoring system based on the predictors could provide guidance for making clinical decisions.